230 results on '"Prelli, Frances"'
Search Results
2. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
3. PrP Peptides as a Tool to Investigate the Pathogenesis of Prion Protein Amyloidoses
4. Peptides Inhibitor of Amyloidogenesis in Alzheimer’s Disease
5. Blocking the Apolipoprotein E/Amyloid-β Interaction as a Potential Therapeutic Approach for Alzheimer's Disease
6. Amelioration of tau related pathology with a novel anti‐prion protein monoclonal antibody in an AD mouse model
7. Human Heavy Chain Disease Protein WIS: Implications for the Organization of Immunoglobulin Genes
8. Synthetic Peptides Homologous to Prion Protein Residues 106-147 Form Amyloid-Like Fibrils in vitro
9. Polymerization of Intact β 2-microglobulin in Tissue Causes Amyloidosis in Patients on Chronic Hemodialysis
10. Human λ Light-Chain Constant Region Gene C λ Mor : The Primary Structure of λ VI Bence Jones Protein Mor
11. Hereditary Cerebral Hemorrhage with Amyloidosis in Patients of Dutch Origin is Related to Alzheimer Disease
12. Primary Structure of an Amyloid Prealbumin Variant in Familial Polyneuropathy of Jewish Origin
13. Blocking the apolipoprotein E/amyloid-[beta] interaction as a potential therapeutic approach for Alzheimer's disease
14. Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer’s Mouse Model With Tau Pathology
15. Apolipoprotein E and Amyloidogenesis
16. Novel Prion Protein Conformation and Glycotype in Creutzfeldt-Jakob Disease
17. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies
18. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP
19. Amyloid fibrils in Gerstmann-Straussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele
20. Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides
21. O4-01-06: SECERNIN-1 IS A NOVEL PHOSPHORYLATED TAU BINDING PROTEIN THAT ACCUMULATES IN ALZHEIMER'S DISEASE AND NOT IN OTHER TAUOPATHIES
22. Proteinase-K-Resistant Prion Protein Isoforms in Gerstmann-Straussler-Scheinker Disease (Indiana Kindred)
23. Prion protein released by platelets
24. Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides
25. P2‐170: SECERNIN‐1 IS A NOVEL EARLY MARKER OF NEUROFIBRILLARY TANGLES IN ALZHEIMER'S DISEASE
26. Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease
27. Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
28. Genetic Heterogeneity of Familial Amyloid Polyneuropathies of Jewish Type
29. Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer’s Disease Related Pathology and Cognitive Decline
30. A MONOCLONAL ANTI-OLIGOMER IGM CROSSES THE BBB AND PRODUCES COGNITIVE RESCUE BY LOWERING OLIGOMERIC FORMS OF BOTH TAU AND Aβ IN AN AD ANIMAL MODEL
31. TARGETING THE APOLIPOPROTEIN E/AMYLOID β INTERACTION BY CPO_Aβ17-21P, A NON-TOXIC AND NON-FIBRILLOGENIC PEPTOID, AMELIORATED Aβ-RELATED PATHOLOGY AND IMPROVED COGNITIVE DECLINE IN A MOUSE MODEL OF ALZHEIMER’S DISEASE
32. SECERNIN-1 IS A NOVEL PHOSPHORYLATED TAU BINDING PROTEIN THAT ACCUMULATES IN ALZHEIMER'S DISEASE AND NOT IN OTHER TAUOPATHIES
33. O4-11-02: Disease Modifying Therapy by the Infusion of an Anti-Conformational Monoclonal Antibody in an Ab and TAU 3XTG Mouse Model of Alzheimer's Disease
34. INSIGHTS FROM NEUROPATHOLOGY AND MODULATION OF INNATE IMMUNITY AS A THERAPEUTIC APPROACH FOR ALZHEIMER'S DISEASE
35. SECERNIN-1 IS A NOVEL EARLY MARKER OF NEUROFIBRILLARY TANGLES IN ALZHEIMER’S DISEASE
36. SECERNIN-1: A NOVEL AMYLOID PLAQUE AND OLIGOMER SPECIES ASSOCIATED PROTEIN
37. Chemical Fluorescent Probe for Detection of Aβ Oligomers
38. P4‐174: Monoclonal antibodies that recognize oligomeric tau and Aβ also recognize pathological structures in parkinson's disease human brains
39. [1] Immunoglobulin G (IgG)
40. Purification of Human Wild-Type or Variant Cystatin C From Conditioned Media of Transfected Cells
41. Methods for Studying Prion Protein
42. P4-372: ANTI-CONFORMATIONAL MONOCLONAL ANTIBODY WITH SELECTIVE PREFERENCE FOR PRP RES STRAINS FROM DIFFERENT ANIMAL SPECIES AND HUMANS
43. Styryl-Based and Tricyclic Compounds as Potential Anti-Prion Agents
44. P3-455: Therapeutic anti-Prion Monoclonal Antibody 6D11 Facilitates PrPsc Degradation in Prion Cell culture model
45. Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease
46. O3-05-06: Treatment of prion infection in vitro and in vivo
47. P1-171: A novel tissue culture model of sporadic Creutzfeldt-Jakob disease
48. P3-463: Development of conformational monoclonal antibodies that detects multiple amyloid proteins
49. P3-441: Conformationally directed immunomodulation for multiple pathological conformers
50. P3-353: Therapeutic mechanisms of anti-prion monoclonal antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.